One‐year follow‐up of patients with acromegaly treated with fixed or titrated doses of lanreotide Autogel<sup>®</sup>

200486 citationsJournal Article

Authors

P. Caron · Hôpital Rangueil

Marie Bex · Universitair Ziekenhuis Leuven

D. R. Cullen · Royal Hallamshire Hospital

Ulla Feldt‐Rasmussen · Rigshospitalet

Antonio Picó · Hospital General Universitario de Alicante Doctor Balmis

Sławomir Pynka · Szczecin Academy of Arts

K. Rácz ·

Abstract

Dose titration of lanreotide Autogel improved GH and IGF-I control in patients with acromegaly beyond that achieved using fixed doses of lanreotide Autogel or lanreotide microparticles. Titrated long-term lanreotide Autogel treatment is well tolerated.

Topics & Keywords

Pituitary Gland Disorders and Treatments Growth Hormone and Insulin-like Growth Factors Neuroendocrine Tumor Research Advances

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Clinical Endocrinology

Volume 60, Issue 6, pp. 734-740

DOI: 10.1111/j.1365-2265.2004.02045.x

Field-Weighted Citation Impact: 4.41